Bronchiectasia clinical trials

Explore recruiting bronchiectasia clinical trials.

Also recruiting in Europe

Bronchiectasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Benefits of inhalation of 7% hypertonic saline solution prior to ELTGOL physiotherapy, in patients with bronchiectasis. A randomized controlled trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase III, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronchiectasis (The AIRTIVITY TM Study)

Poland, Romania, Belgium, Finland, Germany, Croatia +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Bronchiectasia trials by city

Bronchiectasia in Toronto Bronchiectasia in Vancouver Bronchiectasia in Montreal Bronchiectasia in Calgary Bronchiectasia in Edmonton Bronchiectasia in Ottawa Bronchiectasia in Winnipeg Bronchiectasia in Quebec City Bronchiectasia in Hamilton Bronchiectasia in Kitchener Bronchiectasia in London Bronchiectasia in Halifax Bronchiectasia in New York Bronchiectasia in Los Angeles Bronchiectasia in Chicago Bronchiectasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease